Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches

Area of Science:

• Hematology
• Cardiovascular Research
• Molecular Biology

Background:

• Platelets are vital in hemostasis and thrombosis.
• Platelet activation is a key step in thrombotic complications, particularly in atherosclerotic cardiovascular diseases.
• Recent research has significantly advanced our understanding of platelet function.

Purpose of the Study:

• To review the structural and functional characteristics of platelets.
• To elucidate the process of platelet activation and its molecular mechanisms, including inflammation, endothelial dysfunction, and microRNAs (miRs).
• To provide an overview of current antiplatelet agents and drugs under investigation.

Main Methods:

• Literature review of past decades' research on platelets.
• Focus on molecular mechanisms of platelet activation.
• Summary of existing and novel antiplatelet therapies.

Main Results:

• Platelet activation, while essential for vascular injury response, can trigger pathological thrombosis.
• Molecular pathways involving inflammation, endothelial dysfunction, and miRs are implicated in platelet activation.
• A range of antiplatelet agents are available, with novel therapies under development.

Conclusions:

• Understanding platelet activation is critical for managing thrombotic disorders.
• Targeting platelet activation pathways offers therapeutic potential for cardiovascular diseases.
• Ongoing research into novel antiplatelet agents promises improved treatment strategies.